Completed NA INTERVENTIONAL NCT02610192

nSTRIDE APS in Females With Primary Patellofemoral Osteoarthritis

A Prospective Study of a Single Intra-Articular Injection of Autologous Protein Solution in Females With Primary Patellofemoral Osteoarthritis

Sponsor: Zimmer Biomet

Conditions Patellofemoral Osteoarthritis

Interventions nSTRIDE Autologous Protein Solution (APS) Kit

Updated 11 times since 2017 Last updated: Jun 11, 2020 Started: Mar 31, 2016 Primary completion: Jun 30, 2018 Completion: Jun 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Patellofemoral Osteoarthritis and is currently completed. Zimmer Biomet leads this study, which shows 11 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jul 2020 — Jan 2021 [monthly]

Completed NA
Jan 2020 — Jul 2020 [monthly]

Completed NA

Phase: None → NA

▶ Show 6 earlier versions

Jul 2018 — Jan 2020 [monthly]

Completed

Status: Active Not Recruiting → Completed
Jun 2018 — Jul 2018 [monthly]

Active Not Recruiting
Apr 2018 — Jun 2018 [monthly]

Active Not Recruiting

Phase: NA → None
Jun 2017 — Apr 2018 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Feb 2017 — Jun 2017 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zimmer Biomet

Data source: Zimmer Biomet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Deurne, Belgium